CONMED CORPORATION Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax of $3.42 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax · last filed 2026-02-17
- CONMED CORPORATION other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2025 was $3.42M, a 37.53% increase from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2024 was $2.49M, a 62.15% decline from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2023 was $6.58M, a 15.88% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2022 was $7.82M, a 14.69% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 12 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.42M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $2.49M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $6.58M 10-K · filed 2025-02-18 | |
| 2022-12-31 | $7.82M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $9.16M 10-K · filed 2023-02-21 | |
| 2020-12-31 | -$6.50M 10-K · filed 2022-02-22 | -$6.50M 10-K · filed 2021-02-22 |
| 2019-12-31 | $35.00K 10-K · filed 2021-02-22 | |
| 2018-12-31 | -$885.00K 10-K · filed 2020-02-24 | |
| 2017-12-31 | $1.02M 10-K · filed 2019-02-25 | |
| 2016-12-31 | -$755.00K 10-K · filed 2017-02-27 | |
| 2015-12-31 | $7.58M 10-K · filed 2016-02-23 | |
| 2014-12-31 | -$18.78M 10-K · filed 2015-02-23 | |
| 2013-12-31 | -$18.18M 10-K · filed 2014-02-24 | |
| 2012-12-31 | -$1.39M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |